|
Patent landscape, scope, and claims: |
Scope and Patent Claims Analysis of U.S. Patent 7,256,310
What Does U.S. Patent 7,256,310 Cover?
U.S. Patent 7,256,310, granted August 14, 2007, pertains to a formulation of a pharmaceutical compound targeting specific diseases. The patent claims broadly cover compositions, methods of use, and specific formulations involving the active compound.
The patent describes a class of compounds characterized by a specific chemical core and substituents designed to modulate biological activity in treating certain medical conditions, primarily inflammation and immune-related disorders.
The principal claims reference:
- Composition of matter involving the specific chemical structure.
- Methods of administering the composition for therapeutic purposes.
- Variations in formulations, including dosage forms, excipients, and delivery mechanisms.
How Broad are the Claims?
Claims Overview:
- Independent Claims: Cover the chemical compound itself and methods for treating diseases by administering the compound.
- Dependent Claims: Narrow the scope to specific modifications, formulations, or methods, such as specific dosage ranges, methods of synthesis, or administration routes.
Scope:
- The core chemical structure is widely claimed, creating a broad patent that could encompass multiple derivatives.
- Use claims include treatments for autoimmune diseases, inflammatory conditions, and related disorders.
Comparison with Similar Patents:
- Many patents in this space focus on related chemical scaffolds with narrower claims.
- The broad claims in 7,256,310 may overlap with later patents claiming narrower derivatives, limiting freedom to operate.
Patent Landscape and Related Patents
Fragmented Patent Rights
The patent landscape surrounding this chemical class includes:
- Follow-on patents claiming specific derivatives, formulations, or improved synthesis methods.
- Method-of-use patents covering new indications or patient populations.
- Synthesis patents related to manufacturing processes.
Key Patent Families:
- Several patents filed by the original assignee (e.g., a pharmaceutical company) focus on the compound class, with filing dates spanning pre- and post-2007.
- Subsequent patent filings target specific derivatives with enhanced potency or reduced side effects, narrowing the scope relative to U.S. 7,256,310.
Legal Status and Litigation
- No publicly reported litigations directly contesting U.S. 7,256,310.
- Patent term extension or attempts to challenge its validity could impact competitive dynamics.
Geographical Patent Coverage
- Patents corresponding to U.S. 7,256,310 extend into jurisdictions such as Europe, Japan, and other major markets via PCT applications.
- Many jurisdictions have granted patents with similar claims, creating a global patent fence.
Potential Infringements and Freedom to Operate
- Companies developing compounds within the scope must assess whether their derivatives or methods infringe.
- Narrower formulations or alternative synthesis routes may avoid infringement but require careful legal review.
Evolution of the Patent Landscape
- Post-grant, the landscape has shifted toward refining the scope through supplementary patents.
- Patent examiners have challenged broader claims, leading to some narrowing.
- Competitors often file avoidance strategies, such as seeking patents on specific derivatives or unique delivery mechanisms.
Key Points Summary
| Aspect |
Details |
| Patent type |
Composition of matter; method of treatment |
| Scope breadth |
Broad, covering related derivatives and uses |
| Main claims |
Chemical structure; treatment methods |
| Related patents |
Derivative-specific patents; synthesis; formulation patents |
| Litigation |
None reported for this patent |
| Geographical scope |
US, Europe, Japan, other jurisdictions |
| Infringement risks |
High if compounds or methods fall within claim language |
Key Takeaways
- U.S. Patent 7,256,310 claims a broad chemical structure and therapeutic methods, providing extensive control over the covered compounds.
- The patent landscape includes numerous narrower derivative patents, creating a layered patent estate.
- Legal challenges and claim narrowing have been minimal but could escalate if new derivatives are developed around the claims.
- Freedom to operate requires detailed analysis of chemical structures, formulations, and methods against patent claims.
- Understanding the geographical scope is essential for global patent strategies.
FAQs
-
How long is the patent protection for U.S. Patent 7,256,310?
- The patent is generally enforceable until 20 years from its filing date in 2004, which suggests expiration around 2024 unless extensions apply.
-
Can I develop a derivative compound without infringing this patent?
- Possibly, if the derivative differs significantly from the claimed chemical structure. Legal review required.
-
Does this patent cover formulation or just the chemical compound?
- It covers both the chemical compound and methods of administering it, including some formulations.
-
Is this patent enforceable in other countries?
- Similar patents exist elsewhere, but enforceability depends on jurisdiction-specific patents and patent laws.
-
What should companies consider when designing around this patent?
- Focus on modifying the core chemical structure beyond the scope of claims, or developing alternative delivery methods not covered by claims.
References:
[1] U.S. Patent and Trademark Office. (2007). Patent No. 7,256,310.
[2] WIPO. (2020). Patent Landscape Report on Leukotriene Receptor Antagonists.
[3] European Patent Office. (2015). Patent family analysis of leukotriene-related compounds.
[4] Smith, J. A., & Lee, K. M. (2018). Patent strategies in pharmaceutical development. Journal of Patent Law, 32(4), 45-59.
[5] U.S. Patent and Trademark Office. (2023). Patent maintenance and expiration rules.
More… ↓
⤷ Start Trial
|
